drugset / Trial / NCT02899000

A Treatment for Severe Inflammatory Acne Subjects

NCT02899000

Phase 4 Completed 186 enrolled Galderma R&D
NaSingle-groupOpen-labelTreatment

Summary

Demonstrate that a daily treatment regimen of adapalene 0.3%/benzoyl peroxide 2.5% gel + oral Doxycycline 200 mg is effective and safe in severe inflammatory acne with 3 or fewer nodules or cysts (non-nodulocystic) during a 12-week treatment period.

Timeline

Start
2016-07-29
Primary completion
2017-03-28
Completion
2017-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.3 % Topical
Subject Benzoyl Peroxide Other / unclassified 2.5 % Topical
Subject Doxycycline Small molecule 100 mg Oral

Indications